About
Care and conscience are
the core of our corporate values
more
the core of our corporate values
04 Dec,2024
Zylox-Tonbridge 2024 Investor Open Day Successfully Held in Hangzhou
On November 28, Zylox-Tonbridge ("2190.HK", hereinafter referred to as "the Company") successfully hosted its 2024 Investor Open Day in Hangzhou, China. The event attracted more th...
more
26 Aug,2024
Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
HANGZHOU, CHINA, August 20, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK), a leading player in China’s peripheral and neurovascular intervention markets, today announced its interim ...
more
22 Mar,2024
Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
HANGZHOU, CHINA, March 21, 2024 – Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK), a leading medical device company in the peripheral and neurovascular interventional market in China, announc...
more
08 Mar,2024
Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
HANGZHOU, CHINA, MAR 7th, 2024 – Zylox-Tonbridge (2190.HK, "the Company"), a leading medical device company in the peripheral and neurovascular interventional market in China, today announc...
more
22 Feb,2024
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
Zylox-Tonbridge (2190.HK), a medical device company specializing in peripheral and neurovascular interventions, proudly announces the recent marketing approvals granted by the Ministry of Health and P...
more
29 Jan,2024
Zylox-Tonbridge’s ZYLOX Venous Stent System Receives NMPA Marketing Approval
On January 22nd, Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK, hereinafter referred to as "Zylox-Tonbridge" or the "Company") announced that its ZYLOX Peripheral Venous St...
more
